Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Galectin-1,3,9 in the the Non-invasive Diagnosis of Endometriosis

NCT04401592 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT04401592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04401592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Galectin-1,3,9 in the the Non-invasive Diagnosis of Endometriosis
Lead sponsor
Semmelweis University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
September 1, 2025
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis, endometriosis ovary, endometriosis rectovaginal septum